Advertisement

Neuraminidase Studies in Sialidosis

  • Michael Cantz
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 125)

Abstract

In 1968, two patients were described in the literature who exhibited clinical features resembling Hurler disease, yet had a normal urinary excretion of acid mucopolysaccharides. Histological and ultrastructural studies of neuronal, visceral and mesenchymal tissues revealed the lysosomal storage of compounds thought to be acid mucopolysaccharides and glycolipids (BÉRARD et al., 1968; SPRANGER et al., 1968; FREITAG et al., 1971) Together with morphologically similar disorders, these patients were later classified as mucolipidosis I (SPRANGER and WIEDEMANN, 1970). More recent biochemical investigations showed an accumulation of sialic acid-containing compounds in cultured fibroblasts and in leukocytes of such patients (CANTZ et al., 1977; SPRANGER et al., 1977; KELLY and GRAETZ, 1977), and a massive urinary excretion of sialyl oligosaccharides, whose structures resembled the glycan portion of glycoproteins MICHALSKI et al., 1977). In fibroblasts, there was a profound deficiency of an “acid” (presumably lysosomal) neuraminidase towards substrates such as sialyllactose, fetuin, and methoxyphenyl neuraminic acid, whereas other lysosomal hydrolases were within the normal range (CANTZ et al., 1977; SPRANGER et al., 1977; KELLY and GRAETZ, 1977). From these studies it became evident that the metabolic defect in mucolipidosis I consists of an impaired catabolism of glycoproteinderived sialyl oligosaccharides due to the genetic deficiency of a neuraminidase, i.e., that the disease is a sialidosis.

Keywords

Acid Mucopolysaccharide Lysosomal Hydrolase Neuraminic Acid Sandhoff Disease Neuraminidase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. ARONSON N.N. and DE DUVE C. (1968): Digestive activity of lysosomes. II. The digestion of macromolecular carbohydrates by extracts of rat liver lysosomes. J. biol. Chem. 243, 4564–4573PubMedGoogle Scholar
  2. BÉRARD M., TOGA M., BERNARD R., DUBOIS D., MARIANI R. and HASSOUN J. (1968): Pathological findings in one case of neuronal and mesenchymal storage disease. Its relationship to lipidoses and to mucopolysaccharidoses. Path. europ. 3, 172–183Google Scholar
  3. CANTZ M., KRESSE H., BARTON R.W. and NEUFELD E.F. (1972): Corrective factors for inborn errors of mucopolysaccharide metabolism, in “Methods in Enzymology”, GINSBURG V., Ed., Vol. XXVIII, Part B, Academic Press (New York and London), pp. 884–897Google Scholar
  4. CANTZ M., GEHLER J. and SPRANGER J. (1977): Mucolipidosis I: Increased sialic acid content and deficiency of an a -N-acetylneuraminidase in cultured fibroblasts. Biochem. Biophys. Res. Commun. 74, 732–738PubMedCrossRefGoogle Scholar
  5. DAWSON G., MATALON R. and DORFMAN A. (1972): Glycosphingolipids in cultured human skin fibroblasts. II. Characterization and metabolism in fibroblasts from patients with inborn errors of glycosphingolipid and mucopolysaccharide metabolism. J. biol. Chem. 247, 5951–5958PubMedGoogle Scholar
  6. DURAND P., GATTI R., CAVALIERI S., BORRONE C., TONDEUR M., MICHALSKI J.C. and STRECKER G (1977): Sialidosis (mucolipidosis I). Hely. paediat. Acta 32, 391–400Google Scholar
  7. FREITAG F., BLÜMCKE S. and SPRANGER J. (1971): Hepatic ultrastructure in mucolipidosis I (lipomucopolysaccharidosis). Virchows Arch. Path. B7, 189–204Google Scholar
  8. HORVAT A. and TOUSTER O. (1968): On the lysosomal occurence and the properties of the neuraminidase of rat liver and of Ehrlich ascites tumor cells. J. biol. Chem 243, 4380–4390PubMedGoogle Scholar
  9. KAPLAN A., ACHORD D.T. and SLY W.S. (1977): Phosphohexo- syl components of a lysosomal enzyme are recog- nized by pinocytosis receptors on human fibro- blasts. Proc. Nat. Acad. Sci. USA 74, 2026–2030PubMedCrossRefGoogle Scholar
  10. KELLY T.E. and GRAETZ G. (1977): Isolated acid neuraminidase deficiency: a distinct lysosomal storage disease. Amer. J. Med. Genet. 1, 31–46CrossRefGoogle Scholar
  11. LEROY J.G., HO M.W., MACBRINN M.C., ZIELKE K., JACOB J. and O’BRIEN J.S. (1972): I-cell disease: Biochemical studies. Pediat. Res. 6, 752–757PubMedCrossRefGoogle Scholar
  12. MAROTEAUX P., POISSONNIER M., TONDEUR M., STRECKER G. and LEMONNIER M. (1978): Sialidose par deficit en alpha (2–6) neuraminidase sans atteinte neurologique. Mucolipidose de type I ? Arch. Fran?. Péd. 35, 280–291Google Scholar
  13. MICHALSKI J.C., STRECKER G., FOURNET B., CANTZ M. and SPRANGER J. (1977): Structures of sialyl-oligosaccharides excreted in the urine of a patient with mucolipidosis I. FEBS Lett. 79, 101–104PubMedCrossRefGoogle Scholar
  14. NEUFELD E.F. (1974): The biochemical basis for mucopolysaccharidoses and mucolipidoses, in “Progress in Medical Genetics”, STEINBERG A.G. and BEARN A.G., Eds., Vol. X, Grune and Stratton Inc. ( New York and London ), 81–101Google Scholar
  15. O’BRIEN J.S. (1977): Neuraminidase deficiency in the cherry red spot-myoclonus syndrome. Biochem. Biophys. Res. Commun. 79, 1136–1141Google Scholar
  16. SANDC G.N. and NEUFELD E.F. (1977): Recognition and receptormediated uptake of a lysosomal enzyme, a-Liduronidase, by cultured human fibroblasts. Cell 12, 619–627CrossRefGoogle Scholar
  17. SPRANGER J., WIEDEMANN H.R., TOLKSDORF M., GRAUCOB E. and CAESAR R. (1968): Lipomucopolysaccharidose. Eine neue Speicherkrankheit. Zschr. Kinderheilk. 103, 285–306CrossRefGoogle Scholar
  18. SPRANGER J. and WIEDEMANN H.R. (1970): The genetic mucolipidoses. Humangenetik 9, 113–139PubMedCrossRefGoogle Scholar
  19. SPRANGER J., GEHLER J. and CANTZ M. (1977): Mucolipidosis I-a sialidosis. Amer. J. Med. Genet. 1, 21–29CrossRefGoogle Scholar
  20. STRECKER G., MICHALSKI J.C., MONTREUIL J. and FARRIAUX J.P. (1976): Deficit in neuraminidase associated with mucolipidosis II (I-cell disease). Biomedicine 25, 238–239PubMedGoogle Scholar
  21. STRECKER G., PEERS M.C., MICHALSKI J.C., HONDI-ASSAH T., FOURNET B., SPIK G., MONTREUIL J., FARRIAUX J.P., MAROTEAUX P. and DURAND P. (1977): Structure of nine sialyl-oligosaccharides accumulated in urine of eleven patients with three different types of sialidosis, mucolipidosis II and two new types of mucolipidosis. Eur. J. Biochem. 75, 391–403PubMedCrossRefGoogle Scholar
  22. STRECKER G. and MICHALSKI J.C. (1978): Biochemical basis of six different types of sialidosis. FEBS Lett. 85, 20–24PubMedCrossRefGoogle Scholar
  23. THOMAS G.H., TILLER G.E., REYNOLDS L.W., MILLER C.S. and BACE J.W. (1976): Increased levels of sialic acid associated with a sialidase deficiency in I-cell disease (mucolipidosis II) fibroblasts. Biochem. Biophys. Res. Commun. 71, 188–195Google Scholar
  24. THOMAS G.H., TIPTON R.E., CH’IEN T., REYNOLDS L.W. and MILLER C.S. (1978): Sialidase (a-N-acetyl neuraminidase) deficiency: the enzyme defect in an adult with macular cherry-red spots and myoclonus without dementia. Clin. Genet. 13, 369–379Google Scholar
  25. TONDEUR M., VAMOS-HURWITZ E., MOCKEL-POHL S., DEREUME J.P., CREMER N. and LOEB H. (1971): Clinical, biochemical, and ultrastructural studies in a case of chondrodystrophy presenting the I-cell phenotype in tissue culture. J. Pediat. 79, 366–378PubMedCrossRefGoogle Scholar
  26. TULSIANI D.R.P. and CARUBELLI R. (1970): Studies on the soluble and lysosomal neuraminidases of rat liver. J. biol. Chem. 245, 1821–1827PubMedGoogle Scholar
  27. VLADUTIU G.D. and RATTAZZI M.C. (1975): Abnormal lysosomal hydrolases excreted by cultured fibroblasts in I-cell disease (mucolipidosis II). Biochem. Biophys. Res. Commun. 67, 956–964Google Scholar
  28. VLADUTIU G.D. and RATTAZZI M.C. (1978): I-cell disease. Desialylation of ß-hexosaminidase and its effect on uptake by fibroblasts. Biochim. Biophys. Acta 539, 31–36Google Scholar
  29. WARREN L. (1959): The thiobarbituric acid assay of sialic acids. J. biol. Chem. 234, 1971–1975PubMedGoogle Scholar
  30. WENGER D.A., SATTLER M., CLARK C. and WHARTON C. (1976): I-cell disease: Activities of lysosomal enzymes toward natural and synthetic substrates. Life Sci. 19, 413–420PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Michael Cantz
    • 1
  1. 1.Physiologisch-Chemisches InstitutUniversität MünsterMünsterFederal Republic of Germany

Personalised recommendations